Hypothesis: That HBOT can be toxic in the low-pressure range.
The study is a retrospective review of the author's experience treating chronic brain injury
with HBOT, supplemented by cases communicated to the author, who developed untoward effects
during or after their HBOT. The object of the study was to affirm or refute the author's
general impression that there was an optimal dose of HBOT in chronic brain injury which was
lower than the traditional dose applied in chronic non-central nervous system wounding.
Furthermore, when this lower dosage range was exceeded and approached the traditional doses
for non-CNS wounding oxygen toxicity would result. To address these impressions the study
seeks to review the author's medical records and other patient/doctor communications to the
author where side effects of HBOT occurred in the treatment of chronic brain injury and
abstract signs, symptoms, and the dose of HBOT employed.
- Cerebral disorder of greater than one year's duration